- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Swiftly Changing Lifestyle is Propelling Atrial Fibrillation in Developing Countries
Mar 17, 2020
Rochester RHIO Turns to eHealth Technologies to Deliver Solutions for 3D Image Sharing
Mar 06, 2020
Chinese scientists seeking several potential COVID-19 treatment find 'extremely effective' antibodies
Apr 01, 2020
Mako Medical Expands COVID-19 Testing to Help Those on the Front Lines
Apr 20, 2020
Asia Pacific Antibiotics Market Developments by 2019-2027| Sanofi, Novartis, Pfizer, Astellas Pharma
Oct 14, 2020
Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers
May 27, 2020
QIAGEN Launched QIAstat-Dx for Transplant Diagnostics in Europe
Sep 12, 2019
Follow us on
